SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-027227
Filing Date
2023-08-03
Accepted
2023-08-03 16:14:25
Documents
15
Period of Report
2023-08-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vir-20230803.htm   iXBRL 8-K 26832
2 EX-99.1 vir-20230803xex991.htm EX-99.1 149663
7 LOGO image_0.jpg GRAPHIC 16218
  Complete submission text file 0001628280-23-027227.txt   378530

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vir-20230803.xsd EX-101.SCH 2258
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vir-20230803_def.xml EX-101.DEF 15347
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vir-20230803_lab.xml EX-101.LAB 29663
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vir-20230803_pre.xml EX-101.PRE 16021
9 EXTRACTED XBRL INSTANCE DOCUMENT vir-20230803_htm.xml XML 3341
Mailing Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39083 | Film No.: 231140170
SIC: 2836 Biological Products, (No Diagnostic Substances)